For: | Abdel-Razeq R, Bitar L, Bitar ER, Onwuzo C, Abu-Hammour MN, Eren B, Mohamed I, Johnson A, Boustany A, Onwuzo S, Asaad I. Prevalence and risk factors associated with metabolic dysfunction-associated steatohepatitis in patients with Helicobacter pylori infection: A population-based study. World J Hepatol 2024; 16(10): 1169-1176 [PMID: 39474577 DOI: 10.4254/wjh.v16.i10.1169] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v16/i10/1169.htm |
Number | Citing Articles |
1 |
Cheng-Fei Zhao. Association between <i>Helicobacter pylori</i> infection and metabolic dysfunction-associated steatohepatitis: From an analysis of a population-based study. World Journal of Hepatology 2025; 17(2): 102734 doi: 10.4254/wjh.v17.i2.102734
|
2 |
Chao Li, Jiang Nan, Bo-Tao Xu. <i>Helicobacter pylori</i> infection as a contributing factor to metabolic dysfunction-associated steatohepatitis: A population-based insight. World Journal of Hepatology 2025; 17(1): 103228 doi: 10.4254/wjh.v17.i1.103228
|
3 |
Xueying Wang, Zhiying Wei, Qing Xiang, Lijie Tang, Weichun Xie. Therapeutic Potential of Probiotics in Metabolic Dysfunction-Associated Steatohepatitis: A Comprehensive Review. Microorganisms 2025; 13(8): 1894 doi: 10.3390/microorganisms13081894
|
4 |
Guo-E Gou, Ting Li, Chen-Rui Liu, Ting Meng, Ya-Ping Li. Potential mechanisms and therapeutic prospects of the association between <i>Helicobacter pylori</i> infection and metabolic dysfunction-associated steatohepatitis. World Journal of Hepatology 2025; 17(1): 101798 doi: 10.4254/wjh.v17.i1.101798
|
5 |
Jun Young Kim, Byung Soo Kwan, Jung Hwan Cho, Hye In Kim, Nak Gyeong Ko, Mihyeon Jin, Ok Jae Lee. Persistently Active Helicobacter pylori Infection Is Associated with the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease. Journal of Clinical Medicine 2025; 14(4): 1073 doi: 10.3390/jcm14041073
|